| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 3,245,000 | 3,277,000 | 3,079,000 | 3,641,000 | | Cost of Revenue | 1,386,000 | 1,328,000 | 1,213,000 | 1,495,000 | | | Gross Profit | 1,859,000 | 1,949,000 | 1,866,000 | 2,146,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 961,000 | 1,015,000 | 996,000 | 953,000 | | Non Recurring | (98,000) | (105,000) | (125,000) | (399,000) | | Others | 414,000 | 422,000 | 395,000 | 742,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 582,000 | 617,000 | 600,000 | 850,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,000 | 17,000 | 59,000 | 30,000 | | Earnings Before Interest And Taxes | 598,000 | 634,000 | 659,000 | 880,000 | | Interest Expense | 175,000 | 171,000 | 203,000 | 194,000 | | Income Before Tax | 423,000 | 463,000 | 456,000 | 686,000 | | Income Tax Expense | 160,000 | 187,000 | 188,000 | 273,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 263,000 | 276,000 | 268,000 | 413,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 263,000 | 276,000 | 268,000 | 413,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $263,000 | $276,000 | $268,000 | $413,000 |
|
1.49% Nasdaq 
0.27%
Income Statement
